Leiomyosarcoma Clinical Trials 2022

Browse 30 Leiomyosarcoma Medical Studies Across 125 Cities

4 Phase 3 Trial · 329 Leiomyosarcoma Clinics

Reviewed by Michael Gill, B. Sc.
25 Leiomyosarcoma Clinical Trials Near Me
Orlando, FL
Pittsburgh, PA
New York, NY
Saint Louis, MO
More Trial Locations
An interactive map to display trial locations for University of Florida (UF) Health Cancer Center - Orlando Health, University of Pittsburgh Medical Center, The Trustees of Columbia University, Washington University, and 231 more locations.
Most Popular References for Leiomyosarcoma Clinical Trials
Frequency
Citation
1
www.accessdata.fda.gov/drugsatfda_docs (Trabectedin, Gemcitabine, Dacarbazine)
Top Hospitals for Leiomyosarcoma Clinical Trials
Location
Active Leiomyosarcoma Clinical Trials
All Time Trials for Leiomyosarcoma
First Recorded Leiomyosarcoma Trial
Trials
Memorial Sloan Kettering Cancer Center, New York, New York
4
9
2001
Top Treatments for Leiomyosarcoma Clinical Trials
Treatment Name
Active Leiomyosarcoma Clinical Trials
All Time Trials for Leiomyosarcoma
First Recorded Leiomyosarcoma Trial
Trials
Top Cities for Leiomyosarcoma Clinical Trials
City
Active Leiomyosarcoma Clinical Trials
Top Active Site for Leiomyosarcoma Clinical Trials
Trial List
New York, New York
19
Memorial Sloan Kettering Cancer Center
Portland, Oregon
10
Oregon Health & Science University
How many leiomyosarcoma clinical trials are open to youth and / or seniors?
Most Recent Leiomyosarcoma Clinical Trials
Clinical Trial
Began Recruiting Date
Phase
5/23/2022
Phase 2 & 3
Phase 3 Leiomyosarcoma Clinical Trials
Clinical Trial
Began Recruiting Date
Phase
5/23/2022
Phase 2 & 3
7/11/2014
Phase 2 & 3
Pediatric Leiomyosarcoma Clinical Trials
Clinical Trial
Began Recruiting Date
Phase
2/15/2018
Phase 1 & 2
7/11/2014
Phase 2 & 3
Senior Friendly Leiomyosarcoma Clinical Trials
Clinical Trial
Began Recruiting Date
Phase
5/23/2022
Phase 2 & 3

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 27th, 2021

Last Reviewed: August 14th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.